Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, <scp>double‐blind</scp>, <scp>placebo‐controlled</scp> phase 2 trial
Neurogastroenterology & motility/Neurogastroenterology and motility